Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News F-star Therapeutics Inc. FSTX

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:FSTX)

Fundamentals Snapshot (NDAQ:FSTX)

Current News (NDAQ:FSTX)

F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

GlobeNewswire 8 days ago

SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and ZEN Shareholders About Its Ongoing Investigations

PR Newswire July 21, 2022

F-star Therapeutics Announces a License Agreement with Takeda for a Novel Next-Generation Immuno-oncology Bispecific Antibody

GlobeNewswire July 20, 2022

INVESTIGATION ALERT: Halper Sadeh LLP Investigates PCSB, STCN, USWS, FSTX

PR Newswire July 18, 2022

Shareholder Alert - The M&A Class Action Firm Continues Investigating the Merger - FSTX, EPZM, STCN, SIMO, VMW, VHAQ

PR Newswire July 16, 2022

F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX

Business Wire July 15, 2022

FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders

Business Wire July 14, 2022

SHAREHOLDER ALERT: Weiss Law Reminds FSTX, STCN, GRRB, and OBCI Shareholders About Its Ongoing Investigations

PR Newswire July 12, 2022

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates DRE, RDUS, FSTX, RADA, USAK

PR Newswire July 11, 2022

Opinion & Analysis (NDAQ:FSTX)

No current opinion is available.

Bullboard Posts (NDAQ:FSTX)

4 BIOTECH STOCKS FOR YOUR INVESTMENT WATCHLIST!

FSTX, RIGL, CRNX, KLDO,  https://www.aviseanalytics.com/4-biotech-stocks-for-your-investment-watchlist/
AviseAnalytics - August 9, 2021

4 BIOTECH STOCKS FOR YOUR INVESTMENT WATCHLIST!

FSTX, RIGL, CRNX, KLDO   [url=https://www.aviseanalytics.com/4-biotech-stocks-for-your-investment-watchlist/]Read More[/url] ...
AviseAnalytics - August 9, 2021